Cinctive Capital Management LP Has $7.78 Million Position in ICU Medical, Inc. (NASDAQ:ICUI)

Cinctive Capital Management LP grew its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 91.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 50,149 shares of the medical instruments supplier's stock after purchasing an additional 23,954 shares during the period. Cinctive Capital Management LP owned approximately 0.20% of ICU Medical worth $7,782,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Norges Bank acquired a new position in ICU Medical during the 4th quarter valued at about $40,151,000. FMR LLC increased its stake in shares of ICU Medical by 2,676.6% during the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock valued at $18,968,000 after acquiring an additional 100,345 shares during the period. State Street Corp increased its stake in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after acquiring an additional 77,506 shares during the period. Raymond James Financial Inc. bought a new stake in ICU Medical during the fourth quarter worth approximately $10,003,000. Finally, JPMorgan Chase & Co. lifted its position in ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after purchasing an additional 49,108 shares during the period. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Trading Down 0.0 %

ICUI traded down $0.03 during trading on Monday, reaching $139.29. The company had a trading volume of 160,985 shares, compared to its average volume of 265,297. The firm's 50-day simple moving average is $151.64 and its 200 day simple moving average is $162.46. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market cap of $3.42 billion, a price-to-earnings ratio of -30.82 and a beta of 0.86. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26.

Remove Ads

Analysts Set New Price Targets

ICUI has been the topic of a number of research analyst reports. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price on the stock in a report on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.